Indivior Pharmaceuticals Inc (INDV)
Indivior Pharmaceuticals Inc operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in North Chesterfield, VA, US. The stock last traded at $35.82, down 0.50% on the session, giving a market capitalisation of $4.47B. On trailing twelve-month figures it carries a trailing P/E of 12.61, a net margin of 26.7%. Its beta of 1.11 implies it has historically moved more than the broad market.
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Indivior Pharmaceuticals Inc is most often compared with the following Healthcare names: